The IRBLleida biobank collects more than 4,700 samples from COVID-19 patients in Lleida to be used for research
These samples are stored and will be used for future research on this disease.
The biobank of the Lleida Institute for Biomedical Research (IRBLleida) has so far collected 4,787 samples of blood, plasma and serum from 368 patients who have suffered from COVID-19. Also a brief collection of samples of respiratory origin (bronchoaspirates). These samples are stored and will be used for future research on this disease.
These samples are stored and will be used for future research on this disease. "We must thank the patients who collaborate by providing samples, as they are very valuable for future research, and we must also thank all the clinicians involved in the sample collection circuit" explained the coordinator of the biobank, Maria Ruiz. The aim of this initiative is to participate in the creation of a common catalogue of the National Biobank Network so that the scientific community can have SARS-CoV-2 samples from patients who have suffered from COVID-19.
The IRBLleida biobank is the unit responsible for managing the samples and associated data for research purposes. This management includes all the processes of reception, processing, storage and making the biological samples available to the scientific community, guaranteeing at all times the quality of the samples and their traceability in compliance with current legislation.
The IRBLleida biobank encompasses biomedical research in Lleida, both in the health system (Arnau de Vilanova University Hospital and Santa Maria University Hospital) and in the University of Lleida.
The IRBLleida biobank encompasses biomedical research in Lleida